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Introduction. Cervical osteomyelitis is a rare and infrequent complication in patients with head and neck cancer treated with
radioteraphy, in most cases is associated with osteoradionecrosis.
Objectives. We report the case very uncommon complication of radiotherapy in a patient with oropharyngeal cancer treated with
radio-chemotherapy. He presented a cervical osteomyelitis with the particularity of not being associatedwith osteoradionecrosis.
We compare our case with the literature reviewed.
Materials and methods. This case involves a 56-year-old male patient diagnosed with stage T4NlM0 oropharyngeal squamous-cell
cancer (OPC) treatedwithneoadjuvant chemotherapy (3 cycles ofDPF) and radical radiotherapy (70Gy/35 sessions onmacroscopic
areas and 50Gy/25 sessions on microscopic areas) with concomitant Cetuximab (7 cycles, 200mg/m2). He developed an acute and
chronic grade 4 dysphagia that required a tube feeding for enteral nutrition. Four months later, he developed intense pain and
cervical functional impotence, and after a ﬁrst cervical MRI and bone scan with pathological capture in the atlas, a metastatic
disease was suspected. A few days later, he developed fever, outlining the differential diagnostic with infectious osteomyelitis.
After positive haemocultures for anaerobics, a recurrence-free ENT examination and thorax X-ray, cervical CT and MRI, an
osteomyelitis C1–C2 was diagnosed. In the ENT examination detected a necrotic pharyngeal ulcer and the NGT was withdrawn
and was replaced for a gastrostomy tube. Treatment was carried out with intravenous antibiotherapy and an occipital-cervical
arthrodesis.
Results and conclusion. Cervical osteomyelitis without osteoradionecrosis is a rare complication of head and neck cancer treated
with radiotherapy, in our case was able to be associated with pharyngeal mucosal injury produced by NGT. We only found four
similar cases in the literature reviewed.
http://dx.doi.org/10.1016/j.rpor.2013.03.275
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Purpose. To determine the impact of primary tumor and lymph node, 18F-FDG PET-CT standard uptake value (SUV) on early
response to radiation therapy in patients with locally advanced head and neck cancer (LAHNC).
Methods and materials. We studied 62 consecutive patients (median age 58 (36–82)) with LAHNC treated in our center, who under-
went a 18F-FDG-CT scan based radiotherapy planning for HNC fromOctober 2009 to January 2013. Localization: larynx 18 (29.03%);
oral cavity 14 (22.58%), oropharynx 14 (22.58%), nasopharynx 7 (11.30%) and hypopharynx 9 (14.51%). Stage: III (23.4%), IVa (68,8%),
IVb (7.8%). All patients received 3DRT or IMRT with radical intent, and 80% received concurrent chemotherapy. All patients
underwent a CT scan to assess early response, median time from treatment to CT was 36 days (8–153).
Results. Complete response (CR) was achieved in 31 (50%). These results correspond to stages III 5 (8%), and IVa–b 26 (42%). Primary
tumor and lymph node median SUV was 21.03 and 12.67 respectively. We found no relation between nodal or primary tumor
SUV and early response to treatment assessed by CT scan. Median primary tumor SUV was 18.21 for no CR on primary tumor
and 21.77 for CR (p:0.113). Median nodal SUV was 12.37 for nodal CR and 12.97 for no CR (p:0.789).
Conclusion. In our cohort, higher primary tumor and nodal SUV was not associated with lower rates of CR. Longer follow up
is required to draw any conclusions on overall and disease speciﬁc survival. Multi-institutional trials are required to establish
strong conclusion on this matter.
http://dx.doi.org/10.1016/j.rpor.2013.03.276
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Background. The head and neck cancer (HNCA) represents at least 5% of all cancers and most common histologic type is squamous
cell carcinomawith over 90%of cases. The purpose of this studywas to determine the predictors of long survival in these patients.
